Literature DB >> 10556918

Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation.

F Nantel1, D Denis, R Gordon, A Northey, M Cirino, K M Metters, C C Chan.   

Abstract

1 We characterized the regulation of cyclooxygenase-2 (COX-2) at the mRNA, protein and mediator level in two rat models of acute inflammation, carrageenan-induced paw oedema and mechanical hyperalgesia. 2 Carrageenan was injected in the hind paw of rat at low (paw oedema) and high doses (hyperalgesia). COX-2 and prostaglandin E2 (PGE2) levels were measured by RT-PCR and immunological assays. We also determined the distribution of COX-2 by immunohistochemistry. 3 The injection of carrageenan produced a significant and parallel induction of both COX-2 and PGE2. This induction was significantly higher in hyperalgesia than in paw oedema. This was probably due to the 9 fold higher concentration of carrageenan used to provoke hyperalgesia. 4 Immunohistochemical examination showed COX-2 immunoreactivity in the epidermis, skeletal muscle and inflammatory cells of rats experiencing hyperalgesia. In paw oedema however, only the epidermis showed positive COX-2 immunoreactivity. 5 Pretreatment with indomethacin completely abolished the induction of COX-2 in paw oedema but not in hyperalgesia. 6 These results suggest that multiple mechanisms regulate COX-2 induction especially in the more severe model. In carrageenan-induced paw oedema, prostanoid production have been linked through the expression of the COX-2 gene which suggest the presence of a positive feedback loop mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556918      PMCID: PMC1571708          DOI: 10.1038/sj.bjp.0702866

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide.

Authors:  S H Lee; E Soyoola; P Chanmugam; S Hart; W Sun; H Zhong; S Liou; D Simmons; D Hwang
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

2.  Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2.

Authors:  M Murakami; H Kuwata; Y Amakasu; S Shimbara; Y Nakatani; G Atsumi; I Kudo
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

3.  Pathway to carrageenan-induced inflammation in the hind limb of the rat.

Authors:  R Vinegar; J F Truax; J L Selph; P R Johnston; A L Venable; K K McKenzie
Journal:  Fed Proc       Date:  1987-01

4.  Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2.

Authors:  S J Mnich; A W Veenhuizen; J B Monahan; K C Sheehan; K R Lynch; P C Isakson; J P Portanova
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

Review 5.  Renal toxicity of the nonsteroidal anti-inflammatory drugs.

Authors:  M D Murray; D C Brater
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

6.  Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.

Authors:  D A Jones; D P Carlton; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

Review 7.  Prostaglandin and thromboxane biosynthesis.

Authors:  W L Smith; L J Marnett; D L DeWitt
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

8.  Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA.

Authors:  B P Kennedy; C C Chan; S A Culp; W A Cromlish
Journal:  Biochem Biophys Res Commun       Date:  1993-12-15       Impact factor: 3.575

9.  Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.

Authors:  C C Chan; S Boyce; C Brideau; A W Ford-Hutchinson; R Gordon; D Guay; R G Hill; C S Li; J Mancini; M Penneton
Journal:  J Pharmacol Exp Ther       Date:  1995-09       Impact factor: 4.030

10.  Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo.

Authors:  J P Portanova; Y Zhang; G D Anderson; S D Hauser; J L Masferrer; K Seibert; S A Gregory; P C Isakson
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more
  64 in total

1.  Interactions of estradiol and NSAIDS on carrageenan-induced hyperalgesia.

Authors:  Deirtra A Hunter; Gordon A Barr; Kai-Yvonne Shivers; Nicole Amador; Shirzad Jenab; Charles Inturrisi; Vanya Quinones-Jenab
Journal:  Brain Res       Date:  2011-01-31       Impact factor: 3.252

2.  Anti-inflammatory and antinociceptive activities of the leaf methanol extract of Miconia minutiflora (Bonpl.) DC. and characterization of compounds by UPLC-DAD-QTOF-MS/MS.

Authors:  Aline Stamford S G Gatis-Carrazzoni; Fernanda Virgínia Barreto Mota; Tonny Cley Campos Leite; Tatiane Bezerra de Oliveira; Sandra Cabral da Silva; Isla Vanessa Alves Bastos; Maria Bernadete de Souza Maia; Pedro Silvino Pereira; Pedro Paulo Marcelino Neto; Earl Celestino de Oliveira Chagas; Tania Maria Sarmento Silva; Márcia Silva do Nascimento; Teresinha Gonçalves da Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-13       Impact factor: 3.000

3.  Pharmacokinetic-pharmacodynamic modelling of the analgesic effects of lumiracoxib, a selective inhibitor of cyclooxygenase-2, in rats.

Authors:  D A Vásquez-Bahena; U E Salazar-Morales; M I Ortiz; G Castañeda-Hernández; Iñaki F Trocóniz
Journal:  Br J Pharmacol       Date:  2009-12-02       Impact factor: 8.739

4.  Sulfated polysaccharides isolated from the green seaweed Caulerpa racemosa plays antinociceptive and anti-inflammatory activities in a way dependent on HO-1 pathway activation.

Authors:  Natássia Albuquerque Ribeiro; Ticiana Monteiro Abreu; Hellíada Vasconcelos Chaves; Mirna Marques Bezerra; Helena Serra Azul Monteiro; Roberta Jeane Bezerra Jorge; Norma Maria Barros Benevides
Journal:  Inflamm Res       Date:  2014-03-16       Impact factor: 4.575

5.  Ferulic acid ethyl ester diminished Complete Freund's Adjuvant-induced incapacitation through antioxidant and anti-inflammatory activity.

Authors:  Francisco Valmor Macedo Cunha; Bruno de Sousa Gomes; Benedito de Sousa Neto; Alana Rodrigues Ferreira; Damião Pergentino de Sousa; Maria do Carmo de Carvalho e Martins; Francisco de Assis Oliveira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-10-24       Impact factor: 3.000

6.  COX-2 expression and function in the hyperalgesic response to paw inflammation in mice.

Authors:  Naveen K Jain; Tomo-o Ishikawa; Igor Spigelman; Harvey R Herschman
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-10-01       Impact factor: 4.006

7.  Antinociceptive and anti-inflammatory activities of the ethanol extract of Annona muricata L. leaves in animal models.

Authors:  Orlando Vieira de Sousa; Glauciemar Del-Vechio Vieira; José de Jesus R G de Pinho; Célia Hitomi Yamamoto; Maria Silvana Alves
Journal:  Int J Mol Sci       Date:  2010-05-06       Impact factor: 5.923

8.  Characterization of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammation.

Authors:  Claudia Patrignani; David T Lafont; Valeria Muzio; Béatrice Gréco; Rob Hooft van Huijsduijnen; Paola F Zaratin
Journal:  J Inflamm (Lond)       Date:  2010-03-30       Impact factor: 4.981

9.  Pharmacological properties of the ethanol extract of Muehlenbeckia platyclada (F. Muell.) meisn. leaves.

Authors:  Leopoldina Leonor Fagundes; Glauciemar Del-Vechio Vieira; José de Jesus R G de Pinho; Célia Hitomi Yamamoto; Maria Silvana Alves; Paulo César Stringheta; Orlando Vieira de Sousa
Journal:  Int J Mol Sci       Date:  2010-10-15       Impact factor: 5.923

10.  Preferential uptake of the non steroid anti-inflammatory drug diclofenac into inflamed tissues after a single oral dose in rats.

Authors:  A Schweitzer; N Hasler-Nguyen; J Zijlstra
Journal:  BMC Pharmacol       Date:  2009-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.